For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Q2 2026 results

Novartis Financial Results – Q2 2026

Novartis announces the company’s financial results for the second quarter and first half of 2026.

Learn more about the Q2 2026 results
Happy father with daughter on his shoulders under a clear blue sky
Therapeutic areas

Discover our medicines

Close up on the hands of a laboratory technician wearing blue gloves preparing a sample with pipette
Research and development

Explore our science

HCP wearing a medical coat pulling a cart bicycle in rural african village
ESG

Learn about our impact

Two business people smiling in a modern and bright room
Careers

Join our team

Latest news

Jul 27, 2026

  • Story

Small shifts. Big impact. The leadership choices that matter most in the age of AI

Jul 24, 2026

  • Story

How Novartis R&D is advancing the next breakthrough innovations

Jul 21, 2026

  • Ad hoc release

Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed
All news
Collage of two pictures. On the left, a black and white picture taken in the 70s showing a scientist using a microscope in a lab. On the right, a scientist using a microscope in a bright and warm lab

30 years of Novartis, powered by 250 years of innovation

Rooted in a legacy of scientific discovery, Novartis continues to advance breakthrough medicines that redefine the future of care for patients.

Learn more about the 30 years of Novartis
NIBR Operator in Cambridge, Massachusetts
Live. Magazine

The Novartis story

30 years of innovation and engagement.
Read the Novartis story
Business people walking on the Novartis Basel campus

Annual reporting suite

Explore and download our Annual Report 2025, Report on Nonfinancial Matters 2025 and other reporting documents.

Learn more

Resource links

About Novartis
Patients and caregivers
Healthcare professionals
Clinical trials
Pipeline
Products